scanX
Home
Amrutanjan Health Care

Amrutanjan Health Care

804.90
+25.65
(3.29%)
Market Cap (₹ Cr.)
₹2,253
52 Week High
862.60
Book Value
₹
52 Week Low
563.90
PE Ratio
52.91
PB Ratio
7.81
PE for Sector
57.62
PB for Sector
19.92
ROE
18.92 %
ROCE
82.32 %
Dividend Yield
0.49 %
EPS
₹15.56
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
12.50 %
Net Income Growth
38.06 %
Cash Flow Change
13.01 %
ROE
-12.68 %
ROCE
32.27 %
EBITDA Margin (Avg.)
15.48 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
50
30
47
54
58
35
57
63
70
33
58
66
74
37
64
72
89
46
77
85
62
49
96
103
97
81
115
114
112
74
114
101
105
82
103
121
132
88
Expenses
40
27
36
42
48
32
45
50
63
34
43
56
62
39
53
63
68
46
63
71
50
39
64
74
82
64
87
85
90
68
95
85
87
71
92
95
111
80
EBITDA
10
3
11
11
10
4
12
13
8
-1
14
10
12
-1
10
8
21
0
13
14
12
10
32
29
15
17
27
29
22
6
19
16
18
11
11
25
21
8
Operating Profit %
18 %
6 %
20 %
21 %
15 %
8 %
20 %
15 %
10 %
-7 %
23 %
11 %
15 %
-8 %
14 %
9 %
21 %
-3 %
15 %
14 %
15 %
16 %
31 %
26 %
13 %
19 %
21 %
23 %
15 %
5 %
14 %
12 %
13 %
9 %
7 %
18 %
13 %
4 %
Depreciation
1
1
1
1
1
1
1
1
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
2
2
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
9
3
11
11
10
3
11
12
7
-2
14
10
11
-2
9
7
20
-1
12
13
11
9
31
28
14
16
26
28
20
5
17
15
16
9
9
24
20
6
Tax
4
1
3
3
5
1
4
3
4
-0
4
3
5
-1
3
2
6
-0
4
3
3
2
8
7
3
4
7
7
5
2
5
4
4
2
2
6
6
2
Net Profit
6
2
7
9
5
2
7
9
3
-2
9
6
6
-2
6
5
14
-1
8
9
8
6
24
21
10
12
20
21
15
4
13
11
13
7
7
17
14
5
EPS in ₹
4.01
1.17
5.01
5.94
3.22
1.44
4.88
6.35
1.80
-1.03
6.39
4.41
1.96
-0.53
2.28
1.81
4.88
-0.24
2.87
3.25
2.70
2.20
8.06
7.18
3.50
4.12
6.79
7.05
5.09
1.26
4.37
3.67
4.35
2.40
2.36
6.05
4.72
1.60
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
130
149
152
166
188
205
274
350
362
367
Fixed Assets
13
22
27
28
26
26
23
28
49
50
Current Assets
79
95
108
121
140
126
223
275
260
296
Capital Work in Progress
4
1
1
0
0
0
2
17
1
2
Investments
0
0
10
8
18
18
18
13
5
0
Other Assets
113
126
115
131
144
161
232
291
307
315
Total Liabilities
25
28
36
38
42
46
59
85
71
78
Current Liabilities
23
25
32
32
36
39
52
77
63
70
Non Current Liabilities
2
3
4
5
6
7
7
7
8
8
Total Equity
105
120
116
129
146
159
216
265
291
288
Reserve & Surplus
102
118
113
126
143
157
213
262
288
286
Share Capital
3
3
3
3
3
3
3
3
3
3
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
12
3
2
3
-7
-4
-1
3
-1
Investing Activities
-5
1
-0
-8
-11
-14
-88
-36
-2
19
Operating Activities
19
21
8
19
21
18
91
52
20
28
Financing Activities
-12
-11
-5
-9
-7
-12
-7
-17
-15
-48
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
50.02 %
50.02 %
50.02 %
50.02 %
50.02 %
50.02 %
50.02 %
50.02 %
50.04 %
50.04 %
50.59 %
50.59 %
50.59 %
50.59 %
FIIs
2.00 %
1.50 %
1.53 %
1.83 %
1.43 %
1.42 %
0.87 %
0.76 %
0.68 %
0.70 %
0.75 %
0.80 %
1.38 %
1.55 %
DIIs
7.76 %
7.49 %
6.94 %
6.14 %
6.14 %
6.16 %
6.30 %
6.39 %
7.18 %
7.22 %
7.10 %
7.24 %
7.29 %
7.32 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
40.16 %
40.92 %
41.41 %
41.90 %
42.23 %
42.21 %
42.63 %
42.65 %
41.93 %
41.87 %
41.39 %
41.19 %
40.68 %
40.47 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,359.60 1,16,815.97 69.82 10,785.75 11.59 1,656 20.90 47.50
Ajanta Pharma
3,121.15 39,351.06 46.09 4,293.31 11.77 816 18.09 49.72
Gland Pharma
1,841.50 30,430.47 42.14 5,834.96 50.97 772 -25.94 37.24
Eris Lifesciences
1,397.05 18,928.93 49.77 2,032.96 19.85 397 -4.52 62.53
Caplin Point Laboratories
1,965.50 15,241.11 31.91 1,761.04 15.65 461 19.85 57.70
Marksans Pharma
281.22 13,424.98 40.20 2,227.83 16.55 315 26.45 67.40
Shilpa Medicare
901.90 8,720.99 212.33 1,159.77 8.64 32 1,091.53 73.96
Jeena Sikho Lifecare
1,406.80 3,353.63 100.45 207.35 40.06 34 - 55.67
Amrutanjan Health Care
804.90 2,253.29 52.91 192.42 12.50 21 -34.09 56.41
Syncom Formulations
23.18 2,241.90 79.50 238.85 3.11 20 73.41 56.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
56.41
ATR(14)
Volatile
25.59
STOCH(9,6)
Oversold
17.35
STOCH RSI(14)
Neutral
21.60
MACD(12,26)
Bearish
-3.33
ADX(14)
Strong Trend
26.30
UO(9)
Bearish
40.45
ROC(12)
Downtrend But Slowing Down
-0.78
WillR(14)
Neutral
-53.21
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.